BIOL 3111 / 5111: Genomics in Medicine & Disease

A quantitative, mechanistic journey across evolutionary biology, molecular diagnostics, evidence-based pharmacology, and AI-driven precision therapeutics.

👨‍🏫 Instructor: Prof. Sergei Pond 📍 Department: Biology / Institute for Genomics and Evolutionary Medicine 📅 Class Meetings: Tuesdays & Thursdays 17:30–18:50

Course Slide Decks & Materials

📑 Midterm Project Guide → 📜 Full Syllabus & Grading
📢 Current Active Lecture • Thursday, Oct 1 (In Session Today)
Lecture 06: Bacterial Genomics: Commensals vs. Pathogens (Good vs. Evil)
Interactive 42-slide lecture deck covering microbiome chemical ecology, C. diff FMT trials, the 2011 NIH KPC outbreak, colistin resistance in vivo, the Tom Patterson phage rescue, and the 2024 antibacterial pipeline. Complete the In-Class Sprint & Summative Quiz live on Canvas.
🖥️ Open Lecture Slides → 📖 Reading Guide 📥 Snitkin Fig 3 Template 📝 Canvas Sprint & Quiz
Lecture 01 • Week 1

Genomics in Medicine & The AI Frontier

🟢 Completed

Deconstructs foundational myths in modern medicine: why "normal" reference intervals are statistical fictions, how 1750 London infant mortality distorted life expectancy, the evolutionary scar of the Black Death, the economic trap of blockbuster clinical trial averages, and how structure-based genomics cured CML.

Lecture 02 • Week 2

The Architecture of the Human Genome: Physical Molecules, Ploidy & The Missing 8%

🟢 Completed

From digital 1D code to 3D nuclear chromatin, chromosome mechanical segregation, mitochondrial heteroplasmy bottlenecks, the genetics of cis/trans phasing, the historical evolution of the gene concept, and how the Telomere-to-Telomere (T2T) consortium finally finished the 20-year missing 8%.

📄 Required Reading: Nurk et al. (Science, 2022) View on Science (DOI: 10.1126/science.abj6987) →
"The complete sequence of a human genome" • Telomere-to-Telomere (T2T) Consortium
  • Focus 1: Abstract & Introduction — Why was ~8% of the human genome missing for 20 years?
  • Focus 2: Figure 1 & Figure 2 — GRCh38 gaps vs. T2T closed chromosomes; what was hidden inside the heterochromatic repeats?
  • Focus 3: Section "Clinical Implications" — How unresolved repeats caused false-positive clinical variant calls.
Lecture 03 • Week 3

Thousands of Tiny Nudges: GWAS, Complex Traits, and Polygenic Risk Scores

🟢 Completed

From monogenic Mendelian certainties to Fisher's infinitesimal model. Genome-Wide Association Studies (GWAS), Linkage Disequilibrium, Manhattan plots, within-family sibling controls, and the hype audit of Polygenic Indices (PGIs).

📄 Required Reading: Schwaba et al. (Nature, 2026) View on Nature (DOI: 10.1038/s41586-026-10992-9) →
"Robust inference and correlates from genetic associations with personality" • Meta-analysis of 46 cohorts (N > 1.14 Million)
  • Focus 1: Table 1 & Figure 1 — 1,260 lead SNPs; 82% trait-specific architecture vs. overlapping prefrontal cortex gene sets.
  • Focus 2: Figure 4 & Section "Within-Family Analyses" — Sibling controls proving minimal familial confounding compared to educational attainment.
  • Focus 3: Figure 2 & The Hype Audit — Why PGIs explain only 1%–3% of variance and cannot predict individual future behavior.
Lecture 04 • Week 4

Structural Variation, Copy Number Variants (CNVs), and Gene Dosage in Disease

🟢 Completed

From whole-chromosome aneuploidies to submicroscopic microdeletions and prenatal cell-free DNA liquid biopsies. Explores gene dosage balance (triplosensitivity vs. haploinsufficiency in CMT1A and HNPP), non-allelic homologous recombination (NAHR) mediated by low-copy repeats, chromosomal microarray (CMA) resolution and BAF allelic tracks, the ACMG 5-tier classification framework, and Bayesian positive predictive value (PPV) dynamics in prenatal screening.

📄 Study of the Week: The Lancet Neurology (Sept 2026) Multi-Ethnic Dementia Biomarker Cohorts
"Plasma phosphorylated tau 217 (p-tau217) and APOE ε4 dosage across diverse clinical populations"
  • Focus 1: Media Sensation vs. Clinical Reality — Why commercial direct-to-consumer blood tests claim certainty while clinical trial hazard ratios show complex age-dependent progression.
  • Focus 2: Biomarker Sensitivity — Multi-ethnic validation: why biomarker cutoffs established in homogeneous cohorts fail in diverse urban healthcare environments.
  • Focus 3: Diagnostic Prudence — The clinical ethics of screening asymptomatic individuals without disease-modifying therapeutic interventions.
Lecture 05 • Week 5

The Regulatory Genome: Epigenetics, Chromatin Architecture, and Transcriptomics

🟢 Completed

How non-coding variants, chromatin folding, and chemical tags on DNA control cell identity, disease risk, and the rate of biological aging. Explores DNA methylation (5mC) and histone modifications, chromatin accessibility (ATAC-seq), topologically associating domains (TADs) insulated by CTCF, the GTEx Consortium multi-tissue regulatory atlas (v8 Science 2020), cis- and trans-eQTLs, splicing QTLs (sQTLs), single-cell deconvolution of cellular heterogeneity, and Horvath's 353-CpG multi-tissue epigenetic aging clock.

📄 Required Reading: GTEx Consortium (Science, 2020) & Horvath (Genome Biology, 2013) GTEx Science DOI: 10.1126/science.aaz1776 →
"The GTEx Consortium atlas of genetic regulatory effects across human tissues" • Science 369, eaaz1776 (2020)
  • Focus 1: Scope & Cis-eQTL Distance Decay (Figures 1 & 2) — 15,201 RNA-seq samples across 49 tissues; exponential clustering of regulatory variants within 100 kb of the TSS.
  • Focus 2: Splicing QTLs (sQTLs) vs. eQTLs (Figures 3 & 5) — Why intron excision and transcript isoform remodeling show comparable or greater disease GWAS enrichment than total expression.
  • Focus 3: Horvath Epigenetic Aging Clock — Penalized elastic net regression on 353 CpG dinucleotides predicting biological age and mortality risk across 51 human tissues.
Lecture 06 • Week 6

Bacterial Genomics: Commensals vs. Pathogens (Good vs. Evil)

📘 Active Lecture • Oct 1

From the 1:1 cell count reality and symbiotic colonization resistance to hospital outbreak tracing, the antimicrobial resistance crisis, and next-generation therapeutics. Explores gut microbiome ecology and short-chain fatty acids (SCFAs), 16S rRNA amplicon vs. shotgun metagenomics, secondary bile acid biochemistry, Fecal Microbiota Transplantation (FMT) for recurrent Clostridioides difficile (van Nood et al., NEJM 2013), whole-genome sequencing (WGS) for hospital epidemiology (Snitkin et al., Sci Transl Med 2012), 41-SNV genomic barcoding of carbapenem-resistant Klebsiella pneumoniae (KPC-ST258), silent asymptomatic carrier vectors, in vivo evolution of colistin resistance (PmrB), the landmark Tom Patterson pan-drug resistant Acinetobacter baumannii bacteriophage rescue and evolutionary phage steering (Strathdee & Schooley, UCSD), and the 2024 antibacterial clinical pipeline void (Zosurabalpin & Lolamicin).

📄 Required Reading: Snitkin et al. (Sci Transl Med, 2012) & van Nood et al. (NEJM, 2013) Snitkin DOI: 10.1126/scitranslmed.3004129 →
"Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing" • Sci Transl Med 4, 148ra116 (2012)
  • Focus 1: The Outbreak Detective & Intra-Host Diversity (Figures 2 & 3) — 41 SNVs across 18 patients; resolving the Patient 2 vs. Patient 3 temporal inversion paradox and tracking silent carriers.
  • Focus 2: Ecological Reconstitution & Trial Ethics (Figures 2 & 3) — 81–94% cure in recurrent C. diff vs. 31% for vancomycin; why the DSMB halted the trial early.
  • Focus 3: Last-Resort Resistance & Image Annotation Task — In vivo selection of colistin resistance (Table 2) and hands-on transmission map markup.
Lecture 07 • Week 7

Viral Genomics, Recombination & Pandemic Tracking

⏳ Upcoming • Oct 8

High-throughput viral sequencing, intra-host quasispecies evolution, molecular epidemiology, recombination dynamics, and real-time genomic surveillance across HIV-1, SARS-CoV-2, and Avian Influenza (H5N1).

Lecture slides and reading assignments will be published Tuesday, October 6.
Thursday, Oct 8, 2026